
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check the 36-hour washout from lisinopril to sacubitril-valsartan, the change from metoprolol tartrate to carvedilol, the order of titration, spironolactone with an eGFR above 30 and potassium below 5.0, the sick-day holds when potassium reached 5.5, the missed laboratory check after the last dose increases, intravenous iron at a ferritin of 62, angiography without revascularization, the decision against an ICD at an ejection fraction of 38%, and the ocean-safety plan. | ||
| provenance review | not_started | Sources: PBS American Masters, two Honolulu Star-Advertiser articles of 2018, Olympedia, EBSCO, the International Swimming Hall of Fame and the Encyclopedia of World Biography. The Hawaiʻi State Archives, the Bishop Museum, olympics.com, the New York Times obituary and David Davis's biography Waterman were not read; a 1962 wire report found through Papers Past could not be fetched. The heart attack is dated 1952, not 1955. | ||
| safe messaging review | not_started | His Native Hawaiian identity is described as he would describe it, without stereotype; his own healing practices are respected and not described. Mood screening is synthetic and negative. His wife appears only in a documented claim, and no relative or other real person is given a modern statement, decision or health fact. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-09-28 Progress note 07 (C-CDA) | Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium | One to two weeks after a dose change | The panel due one week after the planned sacubitril-valsartan increase was never drawn, because the increase itself did not happen: he put off the laboratory visit twice for work and the nurse's call was not repeated. No laboratory harm resulted (potassium 4.6, creatinine 1.14 today), but the ARNI stayed at the starting dose for about five months, which may have limited his recovery. Corrective action: laboratory tests drawn at the clinic on the day of each change or by the nurse at home, and nurse calls that continue until each step is done |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-03-30 Progress note 02 (C-CDA) | Laboratory | Lipid panel | Ordered | LDL 92 mg/dL at intake; atorvastatin raised to 80 mg; panel due four to twelve weeks after the change |
| 2026-04-27 Progress note 05 (C-CDA) | Referral | Cardiac rehabilitation for heart failure | Ordered | Program booked from late May, when he becomes eligible |
| 2026-09-14 Progress note 06 (C-CDA) | Prevention | Colorectal cancer screening | Ordered | Age 45 to 75; no screening on record; a stool immunochemical (FIT) kit given today |
| 2026-09-14 Progress note 06 (C-CDA) | Prevention | Hepatitis C screening | Ordered | One-time screening for adults 18 to 79; never tested |
None.
None.
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-03-16 | NT-proBNP | 2450 pg/mL (high) | High |
| 2026-03-16 | Glucose | 102 mg/dL (high) | High |
| 2026-03-16 | Ferritin | 62 ng/mL (low) | Low |
| 2026-03-16 | Transferrin saturation | 16% (low) | Low |
| 2026-03-16 | Hemoglobin A1c | 5.9% (high) | High |
| 2026-03-16 | LDL cholesterol | 92 mg/dL (high) | High |
| 2026-03-16 | Triglycerides | 160 mg/dL (high) | High |
| 2026-03-30 | LVEF by echocardiogram | 30% (low) | Low |
| 2026-04-22 | Sodium | 133 mmol/L (low) | Low |
| 2026-04-22 | Potassium | 5.5 mmol/L (high) | High |
| 2026-04-22 | Creatinine | 1.52 mg/dL (high) | High |
| 2026-04-22 | eGFR (CKD-EPI 2021) | 50 mL/min/1.73 m² (low) | Low |
| 2026-09-28 | NT-proBNP | 620 pg/mL (high) | High |
| 2026-09-28 | LVEF by echocardiogram | 38% (low) | Low |